DOMH · Dominari Holdings Inc. · Executive Compensation
Market Cap
$43.88M
Shares
24.24M
Volume · Oct 28
111.51K
Avg daily vol (3M)
198.72K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kyle Wool | President | $2,838,735 |
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $2,776,692 |
| Soo Yu | Special Projects Manager | $2,414,222 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Special Projects Manager | — | $8,305,915 |
| Soo Yu | Special Projects Manager | $8,305,915 |
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $1,000,000 |
| Kyle Wool | President | $600,360 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $1,693,350 |
| Carlos Aldavero | President | $629,589 |
| Darrell Dotson | VP of Drug Development and General Counsel | $317,308 |
| Christopher Devall | VP of Operations | $272,601 |
| Kyle Wool | President | — |
| Special Projects Manager | — | — |
| Soo Yu | Special Projects Manager | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $960,000 |
| Darrell Dotson | VP of Drug Development and General Counsel | $325,000 |
| Christopher Devall | VP of Operations | — |
| Carlos Aldavero | President | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $1,122,251 |
| Darrell Dotson | VP of Drug Development & General Counsel | $318,750 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | Chief Executive Officer, Director, Principal Accounting Officer and Principal Financial Officer | $350,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tim Ledwick | member of the board of directors | Resigned | 2025-09-22 |
| Tim Ledwick | Chief Financial Officer | Appointed | 2025-09-22 |
| Brian Parsley | director | Appointed | 2025-09-10 |
| Soo Yu | member of the Board of Directors | Resigned | 2025-06-27 |
| Ron Lieberman | member of the Board of Directors | Resigned | 2025-05-23 |
| Ron Lieberman | director | Appointed | 2024-12-20 |
| George Way | Chief Financial Officer | Resigned | 2024-06-18 |
| Kyle Wool | President | Appointed | 2023-12-18 |
| Kyle Haug | director | Appointed | 2023-11-13 |
| Paul LeMire | a member of the board of directors | Resigned | 2023-10-10 |
| Anthony Hayes | Chairman | Appointed | 2023-09-22 |
| Robert J. Vander Zanden | director | Resigned | 2023-09-22 |
| Robert J. Vander Zanden | Chairman of the board of directors | Resigned | 2023-09-22 |
| Carlos Aldavero | Dominari Financial | Resigned | 2023-06-06 |
| Carlos Aldavero | President of Dominari Financial | Terminated | 2023-05-22 |
| Matthew B. McCullough | General Counsel | Appointed | 2023-05-05 |
| George Way | Chief Financial Officer | Appointed | 2023-04-03 |
| Christopher Devall | Chief Operating Officer | Appointed | 2023-01-06 |
Leadership
- Anthony Hayes CEO, Chairman, Board Member
- Tim Ledwick CFO
- Christopher Devall COO
- Darrell Dotson General Counsel
- Matthew B. McCullough General Counsel
- Brian Parsley Board Member
- Gregory James Blattner Board Member
- Kyle Haug Board Member
- Kyle Wool Board Member
- Ron Lieberman Board Member